Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
11/2009
11/19/2009WO2009138789A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009WO2009114856A3 Aurora kinase inhibitors
11/19/2009US20090286984 Processes and intermediates for preparing fused heterocyclic kinase inhibitors
11/19/2009US20090286945 e.g. dimethylsilanediyl(cyclopentadienyl)(7-cyclopentadipyrrole)zirconium dichloride; triethylaluminum or alumoxane cocatalyst; homo or copolymerizing ethyelene and propylene; molecular weight control
11/19/2009US20090286811 Fused pyrimidineone compounds as trpv3 modulators
11/19/2009CA2724213A1 Substituted quinazolines as blood platelet lowering agents
11/19/2009CA2724180A1 Substituted quinazolines
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2722970A1 Synthesis of dihydrothieno[3,2-d]pyrimidine diols and similar pyrimidine diols
11/18/2009EP2117311A1 Therapeutic agents
11/18/2009EP1971610B1 Salts of clopidogrel with polyanions and their use for manufacturing pharmaceutical formulations
11/18/2009EP1184379B1 Chromene compound
11/18/2009EP0892789B2 Irreversible inhibitors of tyrosine kinases
11/18/2009EP0764168B1 Heteroatom-functionalized porphyrazines and multimetallic complexes and polymers derived therefrom
11/18/2009CN101583616A Aza-benzothiophenyl compounds and methods of use
11/18/2009CN101583611A Inhibitors of hepatitis C virus
11/18/2009CN101580708A Organic micromolecular photoelectric material
11/17/2009US7618963 Bicyclic heteroaromatic compounds
11/17/2009US7618958 Stereospecific anxiolytic and anticonvulsant agents with reduced muscle-relaxant, sedative-hypnotic and ataxic effects
11/12/2009WO2009137492A1 Heteroaryl-fused macrocyclic pyrimidine derivatives
11/12/2009WO2009135580A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
11/12/2009US20090281137 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/12/2009US20090281082 Polo-like kinases (Plk1); 1-[1-(2-Chlorophenyl)ethyl]-7-imidazo[1,2-a]pyridin-3-yl-1,2,3,4-tetrahydrothieno[3,2-e][1,4]diazepin-5-one; 3-iodoimidazo[1,2-a]pyridine eractant; ANTITUMOR, ANTIPROLIFERATIVE
11/12/2009CA2723429A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
11/11/2009EP2116544A2 Spirocyclic cyclohexane derivatives
11/11/2009EP2116538A1 Condensed tetrahydroquinoline derivative and use thereof for medical purposes
11/11/2009EP2114951A2 Novel phosphodiesterase inhibitors
11/11/2009EP1928508B1 Biotin diaminoderivatives and their conjugates with macrocyclic chelating agents
11/11/2009EP1915379B1 Olanzapine analogs and methods of use thereof
11/11/2009EP1606255B1 Cyclic derivatives as modulators of chemokine receptor activity
11/11/2009EP1313734B1 Aza heterocyclic derivatives and their therapeutic use
11/10/2009US7615560 tricyclic cmpounds; e.g. 3-propyl-5,6,7,8-tetrahydro-3H-benzo[4,5]-thieno[2,3-d]pyrimidin-4-ylidene amine; personal hygiene product, an oral hygiene product, a skin product or a food
11/05/2009WO2009102377A3 Antibiotic tetrahydro-beta-carboline derivatives
11/05/2009US20090275759 Process for preparing dorzolamide
11/05/2009US20090275755 Process for the Preparation of S-(+)-Clopidogrel by Optical Resolution
11/05/2009US20090275585 Novel Compounds and Therapeutic Use Thereof for Protein Kinase Inhibition
11/05/2009US20090275572 Fab i inhibitors
11/05/2009US20090275570 Substituted heterocycles and their use as chk1, pdk1 and pak inhibitors
11/05/2009US20090275558 Substituted sulfonamide compounds
11/05/2009US20090275037 Fluorescent double stranded dna binding dyes
11/04/2009EP2113506A2 Salts of clopidogrel and process for preparation
11/04/2009EP1617806B1 Selective spirocyclic glucocorticoid receptor modulators
11/04/2009CN101573365A Compounds useful as protein kinase inhibitors
11/04/2009CN101573364A Process for the preparation of 4-hydroxythieno[2,3-b]pyridine-5-carbonitriles
11/03/2009US7612207 Method for preparing clopidogrel 1,5-naphthalenedisulfonate or hydrate thereof
11/03/2009US7612092 Nitrogen-containing aromatic derivatives
11/03/2009US7612078 Piperidinylamino-thieno[2,3-D] pyrimidine compounds
11/03/2009US7612075 Anticaogulants; cardiovascular disorders
11/03/2009CA2368834C Bicyclic heteroaromatic compounds useful as lh agonists
10/2009
10/29/2009WO2009132032A2 Sonic hedgehog modulators
10/29/2009WO2009131201A1 Therapeutic agent for intermittent claudication
10/29/2009WO2009130289A1 HYDROGENSULFATE SALT OF 2-ACETOXY-5-(a-CYCLOPROPYLCARBONYL-2-FLUOROBENZYL)-4,5,6,7-TETRAHYDROTHIENO[3,2-c]PYRIDINE AND ITS PREPARATION
10/29/2009WO2009129983A1 Acid addition salts of prasugrel and pharmaceutical compositions comprising the same
10/29/2009WO2009109781A3 Polycyclic organic compounds, polarizing elements and method of production thereof
10/29/2009WO2007146602A8 Substituted 3-amino-thieno[2,3-b] pyridine-2-carboxamide compounds, their preparation and use
10/29/2009US20090270467 5-[(1S,3S,4R)-3-Amino-4-(2,4,5-trifluorophenyl)cyclohexyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-amine, used for treating insulin resistance, hyperglycemia and non-insulin dependent diabetes in mammals
10/29/2009US20090270446 Diamine derivatives
10/29/2009US20090270424 Crystalline N-(4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl)-N'-(2-fluoro-5-(trifluoromethyl)phenyl)urea hydrochloride
10/29/2009US20090270391 THIENOPYRIDINE DERIVATIVE, OR QUINOLINE DERIVATIVE, OR QUINAZOLINE DERIVATIVE, HAVING c-MET AUTOPHOSPHORYLATION INHIBITING POTENCY
10/29/2009US20090270378 Novel tetrahydropyridothiophenes
10/29/2009CA2722248A1 Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation
10/28/2009EP2112155A1 Hydrogensulfate salt of 2-acetoxy-5-(a-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine and its preparation
10/28/2009EP2111406A1 Substituted spirochromanone derivatives as acc inhibitors
10/28/2009EP1751166B1 Mono-, oligo- and polythieno[3,2-b]thiophenes
10/28/2009CN101565425A 6H-thiochromene [3, 4-e] [1, 2, 4] triazole [1, 5-a] pyrimidine compound with anti-inflammatory and anti-fungal activity
10/28/2009CN101565424A 6H-thiochromene [4, 3-d][1, 2, 4] triazole [1, 5-a] pyrimidine class compound with anti-inflammatory and antifungal activities
10/28/2009CN101565423A Thienopyridine derivatives, production method and use thereof
10/28/2009CN100554268C Multicyclic compounds and the use as inhibitors of PARP, VEGFR2 and MLK3 enzymes
10/27/2009US7608622 1 -Phenylerhyl)-6-(3,4,5-trimethoxyphenyl)- 1 ,3-dihydroimidazo[4,5-b]pyrazin-2-one;
10/27/2009CA2465534C Agents useful for reducing amyloid precursor protein and treating dementia and methods of use thereof
10/27/2009CA2415966C Tetrahydro-heterocycloazepinyl pyrimidine derivatives
10/27/2009CA2381885C Isomeric fused pyrrolocarbazoles and isoindolones
10/22/2009WO2009128559A1 [1]benzothieno[3,2-b][1]benzothiophene compound and method for producing the same, and organic electronic device using the same
10/22/2009WO2009077956A3 HETEROCYCLIC INHIBITORS OF AN Hh-SIGNAL CASCADE, MEDICINAL COMPOSITIONS BASED THEREON AND METHODS FOR TREATING DISEASES CAUSED BY THE ABERRANT ACTIVITY OF AN Hh-SIGNAL SYSTEM
10/22/2009US20090264662 PROCESS FOR THE PREPARATION OF 5,6 -DIHYDRO -4H-4(S)-ETHYLAMINO-6(S)-METHYLTHIENO[2,3-b] THIOPYRAN-2-SULFONAMIDE- 7,7 -DIOXIDE AND ITS SALT
10/22/2009US20090264440 Inhibitors of protein tyrosine kinase activity
10/22/2009US20090264423 Serine-threonine protein kinase and parp modulators
10/22/2009US20090263843 Protein labeling with cyanobenzothiazole conjugates
10/22/2009US20090261321 Quinoid Systems as Organic Semiconductors
10/22/2009US20090261300 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same
10/21/2009EP2109615A1 Substituted pyrano [2, 3 - b]pyridine derivatives as cannabinoid-1 receptor modulators
10/21/2009EP1971601B1 N4-phenyl-quinazoline-4 -amine derivatives and related compounds as erbb type i receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
10/21/2009EP1346993B1 Lactam compounds and medical use thereof
10/21/2009CN101563349A Haloalkyl-substituted pyrimidinone derivatives
10/21/2009CN101563345A Pharmaceutical compounds
10/21/2009CN101560213A Polycyclic compound functioned as inhibitor of enzyme parp, vegfr2 and mlk3 and the application
10/15/2009WO2009124746A1 Substituted sulfonamide derivatives
10/15/2009WO2009124653A2 Thienopyrimidines
10/15/2009WO2009124636A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009WO2009093934A3 Substituted 3-sulphonyl-[1,2,3]triazolo [1,5-a]pyrimidines-antagonists of serotonin 5-ht6 receptors and methods for the production thereof
10/15/2009US20090259043 Tricyclic cytoprotective compounds
10/15/2009US20090259008 Vinyl Monomer And Polymer Derived From The Monomer, And Light Emitting Device Using The Polymer
10/15/2009US20090257977 Novel tetrahydropyridothiophenes
10/15/2009DE102008017853A1 Thienopyrimidine Thienopyrimidines
10/15/2009CA2721025A1 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators
10/15/2009CA2720879A1 Substituted sulfonamide derivatives
10/15/2009CA2720878A1 Thienopyrimidines
10/14/2009EP2108651A1 Crystalline form I of 2-methyl-4-(4-methyl-1-piperazinyl) 10H thieno[2,3-B][1,5] benzodiazepine
10/14/2009EP2108641A1 New substituted spiro[cycloalkyl-1,3'-indo]-2'(1'H)-one derivatives and their use as p38 mitogen-activated kinase inhibitors
10/14/2009EP1786774B1 Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
1 ... 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 ... 214